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ABSTRACT
In this case report we describe a 69-year-old male ex-smoker with non-small-cell carcinoma localised within the pulmonary artery, 
misdiagnosed as pulmonary thromboembolism. This case indicates that non-small-cell carcinoma can be localised within the pulmonary 
artery. Furthermore, it emphasises the importance of performing a positron emission tomography scan and diagnostic intraluminal biopsy 
in unexplained lesions in the pulmonary artery to reach the proper diagnosis at the early stages of the disease. The patient is currently 
undergoing concurrent chemotherapy and radiation therapy.
LEARNING POINTS
•	 Tumours	within	the	pulmonary	arteries	are	a	rare	finding	and	rarely	reported,	and	are	often	misdiagnosed	as	pulmonary	thromboembolism.
• If the diagnosis is unclear a positron emission tomography (PET-CT) scan and intravascular biopsy should be considered at early stages 
of the presentation.
• In general, surgery would be the treatment of choice for pulmonary artery tumours but this is not optimal and treatment options remain 
controversial.
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CASE DESCRIPTION 
A 69-year-old male ex-smoker presented to the emergency department with acute-onset right-sided chest pain with dyspnoea. His past 
medical history included chronic obstructive pulmonary disease stadium-3, well controlled with medications. On presentation, his oxygen 
saturation	was	93%.	Physical	examination	of	the	patient	showed	no	abnormalities.	Laboratory	findings	showed	a	normal	full	blood	count,	
normal venous blood gas and C-reactive protein levels, and no evidence of clotting disorders. Conventional chest radiography showed no 
abnormal shadows. The patient was admitted to our hospital for further management. On Day 2 of admission the patient’s general condition 
deteriorated. A computed tomography (CT) chest angiogram was performed which revealed a 5.7 × 4.2 × 5.0 cm mass in the right pulmonary 
artery; no enlarged lymph nodes or signs of metastasis were found (Fig. 1). 
After discussion with several radiologists, a decision was made to manage the patient as a case of thromboembolism occlusion in the right 
pulmonary artery. He received appropriate anticoagulation therapy, but no improvement occurred. A follow-up CT chest angiogram was 
carried	out	2	weeks	later,	which	showed	no	improvement;	however,	a	new	finding	of	1.5	cm	pleural	fluid	in	the	right	lung	was	discovered	(Fig. 
2). 
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Figure 1. Computed tomography (CT) chest angiogram 2 days after 
presentation showing a mass within the right main pulmonary artery 
(arrows).
A	decision	was	made	to	proceed	further	with	magnetic	resonance	imaging	(MRI)	of	the	chest	which	revealed	increasing	pleural	fluid	with	
intraluminal	filling	defects	involving	the	right	pulmonary	artery,	citing	pulmonary	thromboembolism	as	the	main	differential	diagnosis	(Fig. 
3). A PET-CT scan was performed after a multidisciplinary conference, which revealed a large invasive obstructing homogenous mass in 
the	right	pulmonary	artery	with	high	fluorodeoxyglucose	(FDG)	uptake	of	25.2	SUV	max,	no	FDG	uptake	in	mediastinal	 lymph	nodes	or	
other organs; the differential diagnoses included pulmonary thromboembolism and an intrapulmonary artery tumour (Fig. 4). The patient 
underwent endoscopy-guided biopsy of the mass and histopathology was consistent with the diagnosis of non-small-cell carcinoma. The 
patient is currently receiving ongoing chemotherapy and radiotherapy. 
Figure 2. Computed tomography (CT) chest angiogram 2 weeks 
later showing no improvement in the mass localised within the right 
pulmonary artery (arrows).
Figure 3. Magnetic resonance imaging (MRI) chest scan showing multiple filling defects in the right main pulmonary 
artery (arrows).
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DISCUSSION
We experienced a case of a man with non-small-cell carcinoma which was exclusively localised within the right pulmonary artery. To the 
best of our knowledge, no similar cases have been reported in the literature previously. The pulmonary vessels may be involved by different 
primary and secondary tumours. The primary aetiologies of masses existing in the intrapulmonary artery include angiosarcoma, pulmonary 
thromboembolism, tumour embolisation from cancers of other organs and invasion of a primary lung cancer into the intravascular lumen[1–8]. 
There are very few reports describing intravascular tumours within the pulmonary arteries in the literature [6]. 
In	our	case,	the	patient	presented	with	acute-onset	chest	pain	and	the	first	CT	chest	angiogram	showed	a	filling	defect	in	the	right	pulmonary	
artery.	The	radiologists	were	divided	into	two	groups,	a	group	that	suspected	that	the	radiological	findings	were	consistent	with	pulmonary	
thromboembolism	and	another	group	 that	completely	disagreed	with	 this	and	suspected	 the	findings	 to	be	more	sinister.	The	patient’s	
symptoms	did	not	improve	and	a	follow-up	CT	chest	angiogram	showed	no	change	in	the	filling	defect	despite	appropriate	anticoagulation	
therapy. The turning point in this case was when the patient underwent a PET-CT scan which showed malignant features with a differential 
diagnosis of sarcoma. We found no evidence of metastasis from any other organs.
Previous case reports have shown that clinical and imaging manifestations of intrapulmonary tumours may mimic those of pulmonary 
embolism,	and	therefore,	reaching	a	diagnosis	before	biopsy	or	autopsy	is	difficult [1,4,8]. Dyspnoea, chest pain, cough and haemoptysis are the 
most	common	presenting	symptoms	in	both	conditions.	Furthermore,	both	of	the	diseases	initially	appear	as	intraluminal	filling	defects	in	the	
pulmonary artery systems on contrast-enhanced CT scans. It is very important to differentiate between the diseases to avoid misdiagnosis 
of potentially fatal malignancy and unnecessary anticoagulation therapy.
In the present case, PET-CT scanning provided crucial information for diagnosis, since the diagnostic biopsy was performed based on the 
abnormal	findings	from	the	PET-CT	scan.	A	study	in	2013	reported	that	PET-CT	scans	may	be	beneficial	in	making	a	differential	diagnosis	
between primary intrapulmonary tumours and pulmonary thromboembolism[9]. There have been previous case reports of metastasis or 
direct invasion to the pulmonary artery from other organs[10].	However,	in	this	case,	we	found	no	systemic	or	imaging	findings	that	indicated	
the presence of malignancy in other organs.
Our	conclusion	 is	 that	non-small-cell	 carcinoma	can	be	confined	within	 the	pulmonary	arteries	and	that	clinicians	should	maintain	high	
clinical	suspicion	of	intraluminal	primary	tumours	in	patients	with	a	filling	defect	in	the	pulmonary	artery	without	any	underlying	risk	factors	
for pulmonary thromboembolism and worsening of the symptoms despite appropriate anticoagulation therapy.
Figure 4. Positron emission tomography (PET-CT) scan showing fluorodeoxyglucose (FDG) uptake in the mass in the right main pulmonary artery (arrows) with precise FDG uptake 
measurements. 
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